Novo Nordisk Secures $1 Billion Deal with Lexicon Pharmaceuticals for Innovative Obesity Treatment Business Novo Nordisk Secures $1 Billion Deal with Lexicon Pharmaceuticals for Innovative Obesity Treatment The Scientific Reporters March 29, 2025 0 Introduction In a strategic move to enhance its obesity treatment portfolio, Novo Nordisk has entered into a... Read More Read more about Novo Nordisk Secures $1 Billion Deal with Lexicon Pharmaceuticals for Innovative Obesity Treatment
